Daniel L. Alkon

5 Patents

• US126017502026

  Diagnosing Mild Cognitive Impairment (MCI), Predicting Alzheimer's Disease (AD) Dementia Onset, and Screening and Monitoring Agents for Treating Mci or Preventing Dementia Onset

  WEST VIRGINIA UNIVERSITY

  0 cites
• US124052682025

  Lymphocyte-based Morphometric Test for Alzheimer's Disease

  Neurodiagnostics LLC

  0 cites
• US120168372024

  Halogenated Esters of Cyclopropanated Unsaturated Fatty Acids for Use in the Treatment of Neurodegenerative Diseases

  Synaptogenix, Inc.

  0 cites
• US118263452023

  Dosing Regimens of PKC Activators

  Synaptogenix, Inc.

  0 cites
• US118207452023

  Pkc-activating Compounds for the Treatment of Neurodegenerative Diseases

  Synaptogenix, Inc.

  0 cites